Page last updated: 2024-09-05

2'-hydroxyflavanone and Lung Neoplasms

2'-hydroxyflavanone has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awasthi, S; Chikara, S; Horne, D; Salgia, R; Singhal, J; Singhal, SS1
Chang, HR; Chen, PN; Chu, SC; Hsiao, YC; Hsieh, YS; Kuo, WH; Lin, TH; Yang, WE1

Other Studies

2 other study(ies) available for 2'-hydroxyflavanone and Lung Neoplasms

ArticleYear
RLIP inhibition suppresses breast-to-lung metastasis.
    Cancer letters, 2019, 04-10, Volume: 447

    Topics: Animals; ATP-Binding Cassette Transporters; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Flavanones; GTPase-Activating Proteins; Humans; Lung; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Xenograft Model Antitumor Assays

2019
Flavanone and 2'-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway.
    Chemico-biological interactions, 2007, May-01, Volume: 167, Issue:3

    Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavanones; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Structure; Neoplasm Metastasis; Peptide Hydrolases; Phosphorylation; Xenograft Model Antitumor Assays

2007